tiprankstipranks
Advertisement
Advertisement

HK:2256 Stock Latest News

Abbisko Wins China IND Nod for Pan-KRAS Cancer Drug ABSK211
Company AnnouncementsAbbisko Wins China IND Nod for Pan-KRAS Cancer Drug ABSK211
1d ago
2256
Abbisko Sets August Board Meeting to Approve Interim Results and Weigh Dividend
PremiumCompany Announcements
Abbisko Sets August Board Meeting to Approve Interim Results and Weigh Dividend
17d ago
2256
Abbisko Wins FDA IND Clearance for Pan-KRAS Cancer Drug ABSK211
PremiumCompany Announcements
Abbisko Wins FDA IND Clearance for Pan-KRAS Cancer Drug ABSK211
1M ago
2256
Abbisko and AstraZeneca Launch Joint Trial of Novel NSCLC Combination
PremiumCompany Announcements
Abbisko and AstraZeneca Launch Joint Trial of Novel NSCLC Combination
2M ago
2256
Abbisko Showcases Promising Phase II FGFR2-Targeted Combo Data in Advanced Gastric Cancer
PremiumCompany Announcements
Abbisko Showcases Promising Phase II FGFR2-Targeted Combo Data in Advanced Gastric Cancer
2M ago
2256
Abbisko Deepens Lilly Partnership in Multitarget Drug R&D Deal Worth Up to US$1.9 Billion
PremiumCompany AnnouncementsAbbisko Deepens Lilly Partnership in Multitarget Drug R&D Deal Worth Up to US$1.9 Billion
2M ago
2256
Abbisko Showcases Advanced Modeling for Liver Cancer Drug ABSK-011 at European Meeting
Premium
Company Announcements
Abbisko Showcases Advanced Modeling for Liver Cancer Drug ABSK-011 at European Meeting
3M ago
2256
Abbisko Shareholders Back All AGM Resolutions, Bolstering Capital and Governance Flexibility
Premium
Company Announcements
Abbisko Shareholders Back All AGM Resolutions, Bolstering Capital and Governance Flexibility
3M ago
2256
Abbisko Cayman Raises HK$517 Million Through Share Placing to Fund Drug Development
PremiumCompany Announcements
Abbisko Cayman Raises HK$517 Million Through Share Placing to Fund Drug Development
4M ago
2256
Abbisko Moves to Modernise Governance With Digital-Ready Articles Update
PremiumCompany Announcements
Abbisko Moves to Modernise Governance With Digital-Ready Articles Update
4M ago
2256
Abbisko Cayman Sets 2026 AGM to Approve Results, Board Changes and 20% Share Issue Mandate
PremiumCompany Announcements
Abbisko Cayman Sets 2026 AGM to Approve Results, Board Changes and 20% Share Issue Mandate
4M ago
2256
Abbisko Showcases Broad Oncology Pipeline with Pan‑KRAS Data at 2026 AACR
PremiumCompany Announcements
Abbisko Showcases Broad Oncology Pipeline with Pan‑KRAS Data at 2026 AACR
4M ago
2256
Abbisko Cayman to Raise HK$517 Million via Discounted Share Placing for R&D Push
PremiumCompany AnnouncementsAbbisko Cayman to Raise HK$517 Million via Discounted Share Placing for R&D Push
4M ago
2256
Abbisko Grants 290,000 Share Options to Employees Under Post-IPO Scheme
Premium
Company Announcements
Abbisko Grants 290,000 Share Options to Employees Under Post-IPO Scheme
4M ago
2256
Abbisko Wins EMA Orphan Drug Status for Liver Cancer Therapy Irpagratinib
Premium
Company Announcements
Abbisko Wins EMA Orphan Drug Status for Liver Cancer Therapy Irpagratinib
5M ago
2256
Abbisko Wins FDA IND Clearance for Pediatric Achondroplasia Drug ABSK061
PremiumCompany Announcements
Abbisko Wins FDA IND Clearance for Pediatric Achondroplasia Drug ABSK061
5M ago
2256
Abbisko Wins FDA Orphan Drug Status for Achondroplasia Candidate ABSK061
PremiumCompany Announcements
Abbisko Wins FDA Orphan Drug Status for Achondroplasia Candidate ABSK061
5M ago
2256
Abbisko Starts Phase II Trial of Irpagratinib Combo for Advanced Liver Cancer
PremiumCompany Announcements
Abbisko Starts Phase II Trial of Irpagratinib Combo for Advanced Liver Cancer
5M ago
2256
Abbisko Wins FDA Rare Pediatric Disease Status for Achondroplasia Drug ABSK061
PremiumCompany Announcements
Abbisko Wins FDA Rare Pediatric Disease Status for Achondroplasia Drug ABSK061
5M ago
2256
Abbisko’s TGCT Drug Pimicotinib Clears Key Global Milestone With Lancet Phase 3 Publication
PremiumCompany AnnouncementsAbbisko’s TGCT Drug Pimicotinib Clears Key Global Milestone With Lancet Phase 3 Publication
5M ago
2256
Abbisko Advances KRAS G12D Cancer Program With First Patient Dosed in ABSK141 Trial
Premium
Company Announcements
Abbisko Advances KRAS G12D Cancer Program With First Patient Dosed in ABSK141 Trial
6M ago
2256
Abbisko Chairman Boosts Stake, Signalling Confidence While Maintaining Public Float
Premium
Company Announcements
Abbisko Chairman Boosts Stake, Signalling Confidence While Maintaining Public Float
6M ago
2256

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >